Accent Microcell Limited (NSE:ACCENTMIC)
435.50
-4.35 (-0.99%)
Jun 17, 2026, 3:30 PM IST
Accent Microcell Revenue
In the fiscal year ending March 31, 2026, Accent Microcell had annual revenue of 3.56B INR with 34.33% growth. Accent Microcell had revenue of 1.39B in the half year ending September 30, 2025, with 27.51% growth.
Revenue
3.56B
Revenue Growth
+34.33%
P/S Ratio
2.57
Revenue / Employee
18.53M
Employees
192
Market Cap
9.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.56B | 909.26M | 34.33% |
| Mar 31, 2025 | 2.65B | 192.53M | 7.84% |
| Mar 31, 2024 | 2.46B | 483.37M | 24.50% |
| Mar 31, 2023 | 1.97B | 315.51M | 19.04% |
| Mar 31, 2022 | 1.66B | 322.98M | 24.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 8.54B |
| Zenith Drugs | 1.76B |
| Infinium Pharmachem | 1.57B |
| Quest Laboratories | 1.26B |
| Sotac Pharmaceuticals | 1.02B |
| Sunrest Lifescience | 708.33M |
| Vilin Bio Med | 422.63M |
| Medicamen Organics | 226.30M |